Global Drug Screening Market to Reach USD 15.6 Billion by 2029, Driven by Rising Substance Abuse and Technological Advancements

Mordor Intelligence has released a new report on the Drug Screening Market, providing an in-depth analysis of trends, growth factors, and future outlooks.

The Drug Screening Market is projected to be valued at USD 7.30 billion in 2024 and is anticipated to grow to USD 15.60 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 16.36% during the forecast period (2024-2029). Driven primarily by factors such as the increasing prevalence of drug and alcohol use, strict regulations for alcohol and drug testing, substantial government funding for pharmaceutical research, and accelerated regulatory approvals.

Report Overview - https://www.mordorintelligence.com/industry-reports/drug-screening-market

Key Trends Driving Drug Screening Market

Escalating Substance Abuse Rates

The surge in drug and alcohol consumption worldwide has heightened the demand for effective screening solutions. For instance, approximately 83.4 million adults (29%) in the European Union have reportedly used illicit drugs at least once, according to the 2023 European Drug Report.

Stringent Regulatory Frameworks

Governments globally are implementing rigorous regulations mandating drug and alcohol testing, particularly in safety-sensitive industries. These policies aim to enhance public safety and reduce substance abuse-related incidents, thereby propelling the adoption of drug screening products and services.

Technological Innovations in Screening Methods

Advancements in screening technologies, such as the development of rapid testing devices and sophisticated immunoassays, have significantly improved the accuracy and efficiency of drug detection. Companies are continually enhancing their product portfolios to meet the evolving demands of the market. For example, in December 2023, Quest Diagnostics launched a new confirmatory testing service for novel psychoactive substances, covering a broad array of drug classes.

Market Segmentation

The drug screening market is segmented based on product and service, sample type, end user, and geography:

By Product and Service:

Consumables: Includes reagents, assay kits, and other consumable materials used in drug testing procedures.

Instruments: Comprises analytical devices such as chromatography instruments and immunoassay analyzers.

Rapid Testing Devices: Portable kits designed for quick on-site drug detection.

Services: Encompasses laboratory services, drug testing programs, and related support services.

By Sample Type:

Urine Samples: The most commonly used sample type due to its ease of collection and established testing protocols.

Oral Fluid Samples: Gaining popularity for its non-invasive collection method and ability to detect recent drug use.

Hair Samples: Provides a longer detection window, useful for identifying long-term substance use.

Other Samples: Includes blood, sweat, and breath samples, each offering unique advantages in specific testing scenarios.

By End User:

Drug Testing Laboratories: Specialized facilities conducting comprehensive drug analyses.

Hospitals: Healthcare institutions utilizing drug screening for patient care and diagnostic purposes.

Other End Users: Encompasses workplaces, law enforcement agencies, and educational institutions implementing drug testing programs.

By Geography:

North America: Holds the largest market share, driven by high substance abuse rates and stringent testing regulations.

Europe: Significant market presence due to increasing drug consumption and supportive government initiatives.

Asia-Pacific: Expected to witness the fastest growth, attributed to rising awareness and expanding healthcare infrastructure.

Middle East & Africa: Emerging market with growing adoption of drug screening practices.

South America: Experiencing gradual market growth influenced by evolving regulatory landscapes.

Get a Customized Report Tailored to Your Requirements: https://www.mordorintelligence.com/market-analysis/drug-screening

Key Players

The drug screening market is characterized by a moderate level of competition, with several key players contributing to its growth:

Quest Diagnostics

Abbott Laboratories:

Thermo Fisher Scientific, Inc.

Siemens Healthineers

LabCorp (Laboratory Corporation of America Holdings)

These companies are actively engaged in research and development to introduce advanced products and expand their market presence.

Industry Related Reports:

Drugs of Abuse Testing Market: The report highlights the Global Drugs of Abuse Testing Market Revenue and Analysis. The market is segmented by Product Type (Analyzers, including Immunoassay Analyzers, Chromatographic Devices, and Breath Analyzers; Rapid Testing Devices, such as Urine Testing Devices and Oral Fluid Testing Devices; and Consumables), Sample Type (Saliva, Urine, Blood, and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/drugs-of-abuse-testing-market

At Home Drug of Abuse Testing Market: The report highlights Drug of Abuse Testing Market Trends, with the market segmented by Type (Test Cups, Test Strips, and Others), Sample Type (Saliva, Urine, Blood, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/at-home-drug-of-abuse-testing-market

Toxicology Drug Screening Market: The report highlights Toxicology Drug Screening Market Revenue and Growth Analysis, segmented by Testing Type (In Vitro, In Vivo, and In Silico), Product (Instruments, Reagents and Consumables, Animal Models, Software, and Other Products), Application (Immunotoxicity, Systemic Toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/toxicology-drug-screening-market

Conclusion

The global drug screening market is on a robust growth trajectory, fueled by rising substance abuse rates, stringent regulatory requirements, and continuous technological advancements. As key players continue to innovate and expand their offerings, the market is expected to witness substantial growth, contributing significantly to public health and safety worldwide.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.